All Stories

  1. Regulation of hepatic autophagy by stress-sensing transcription factor CREBH

    Article • The FASEB Journal, July 2019, Federation of American Societies For Experimental Biology (FASEB)

    Dr Li Wang, Kezhong Zhang

  2. H19 Is Expressed in Hybrid Hepatocyte Nuclear Factor 4α+ Periportal Hepatocytes but Not Cytokeratin 19+ Cholangiocytes in Cholestatic Livers

    Article • Hepatology Communications, September 2018, Wiley

    Dr Li Wang

  3. Nuclear receptors and liver disease: Summary of the 2017 basic research symposium

    Article • Hepatology Communications, June 2018, Wiley

    Dr Li Wang

  4. MicroRNA-26-5p functions as a new inhibitor of hepatoblastoma by repressing lin-28 homolog B and aurora kinase a expression

    Article • Hepatology Communications, May 2018, Wiley

    Dr Li Wang

  5. Loss of PDK4 switches the hepatic NF-κB/TNF pathway from pro-survival to pro-apoptosis

    Article • Hepatology, May 2018, Wiley

    Dr Li Wang

  6. Farnesoid X receptor signaling activates the hepatic X-box binding protein 1 pathway in vitro and in mice

    Article • Hepatology, May 2018, Wiley

    Dr Li Wang

  7. Cyclophilin D deficiency attenuates mitochondrial perturbation and ameliorates hepatic steatosis

    Article • Hepatology, May 2018, Wiley

    Dr Li Wang

  8. The Role of Cyclic Nucleotides in Compensatory Hepatocyte Proliferation

    Article • Current Drug Metabolism, February 2018, Bentham Science Publishers

    Dr. José E Manautou, Dr Li Wang

  9. High-mobility-group protein 2 regulated by microRNA-127 and small heterodimer partner modulates pluripotency of mouse embryonic stem cells and liver tumor initiating cells

    Article • Hepatology Communications, August 2017, Wiley

    Dr Li Wang

  10. H19 promotes cholestatic liver fibrosis by preventing ZEB1-mediated inhibition of epithelial cell adhesion molecule

    Article • Hepatology, August 2017, Wiley

    Dr Li Wang

  11. LncRNA AK054921 and AK128652 are potential serum biomarkers and predictors of patient survival with alcoholic cirrhosis

    Article • Hepatology Communications, August 2017, Wiley

    Dr Li Wang

  12. A novel role for CRTC2 in hepatic cholesterol synthesis through SREBP-2

    Article • Hepatology, June 2017, Wiley

    Dr Li Wang

  13. Preserving LXR by inhibiting T39: A step closer to treating atherosclerosis and steatohepatitis?

    Article • Hepatology, December 2016, Wiley

    Dr Li Wang

  14. Long noncoding RNA MEG3 induces cholestatic liver injury by interaction with PTBP1 to facilitate shp mRNA decay

    Article • Hepatology, December 2016, Wiley

    Dr Li Wang

  15. Pyruvate Dehydrogenase Kinase 4 Deficiency Results in Expedited Cellular Proliferation through E2F1-Mediated Increase of Cyclins

    Article • Molecular Pharmacology, December 2016, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr Li Wang

  16. Metabolomics Analysis Revealed Distinct Cyclic Changes of Metabolites Altered by Chronic Ethanol-Plus-Binge andShpDeficiency

    Article • Alcoholism Clinical and Experimental Research, October 2016, Wiley

    Dr Li Wang

  17. Nuclear Receptors as Therapeutic Targets in Liver Disease: Are We There Yet?

    Article • The Annual Review of Pharmacology and Toxicology, January 2016, Annual Reviews

    Dr XI ZHANG, Dr Li Wang

  18. Small heterodimer partner/neuronal PAS domain protein 2 axis regulates the oscillation of liver lipid metabolism

    Article • Hepatology, January 2015, Wiley

    Dr Li Wang